{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:42:21Z","timestamp":1784583741190,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11934-020-0953-x","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T09:02:41Z","timestamp":1579510961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Kidney Transplantation in Transgender Patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Joshua S.","family":"Jue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Alameddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"issue":"1","key":"953_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1526924816632132","volume":"26","author":"DA Hoch","year":"2016","unstructured":"Hoch DA, Bulman M, McMahon DW. Cultural sensitivity and challenges in management of the transgender patient with ESRD in transplantation. Prog Transplant. 2016;26(1):13\u201320. https:\/\/doi.org\/10.1177\/1526924816632132.","journal-title":"Prog Transplant"},{"issue":"4","key":"953_CR2","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-13-0493","volume":"169","author":"K Wierckx","year":"2013","unstructured":"Wierckx K, Elaut E, Declercq E, Heylens G, de Cuypere G, Taes Y, et al. Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol. 2013;169(4):471\u20138. https:\/\/doi.org\/10.1530\/EJE-13-0493.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"953_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/0022146512474429","volume":"54","author":"GJ Gates","year":"2013","unstructured":"Gates GJ. Demographics and LGBT health. J Health Soc Behav. 2013;54(1):72\u20134. https:\/\/doi.org\/10.1177\/0022146512474429.","journal-title":"J Health Soc Behav"},{"issue":"14","key":"953_CR4","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1042\/CS20160047","volume":"130","author":"G Cobo","year":"2016","unstructured":"Cobo G, Hecking M, Port FK, et al. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. Clin Sci (Lond). 2016;130(14):1147\u201363. https:\/\/doi.org\/10.1042\/CS20160047.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"953_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/157339911794273982","volume":"7","author":"S Doublier","year":"2011","unstructured":"Doublier S, Lupia E, Catanuto P, Elliot SJ. Estrogens and progression of diabetic kidney damage. Curr Diabetes Rev. 2011;7(1):28\u201334.","journal-title":"Curr Diabetes Rev"},{"issue":"4","key":"953_CR6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1161\/HYPERTENSIONAHA.107.101345","volume":"51","author":"R Iliescu","year":"2008","unstructured":"Iliescu R, Reckelhoff JF. Sex and the kidney. Hypertens (Dallas, Tex 1979). 2008;51(4):1000\u20131. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.101345.","journal-title":"Hypertens (Dallas, Tex 1979)"},{"key":"953_CR7","doi-asserted-by":"publisher","unstructured":"Silbiger S, Neugarten J. Gender and human chronic renal disease. Gend Med. 2008, 5 Suppl A:S3\u2013S10. https:\/\/doi.org\/10.1016\/j.genm.2008.03.002.","DOI":"10.1016\/j.genm.2008.03.002"},{"key":"953_CR8","doi-asserted-by":"publisher","unstructured":"Yanes LL, Sartori-Valinotti JC, Reckelhoff JF. Sex steroids and renal disease: lessons from animal studies. Hypertens (Dallas, Tex 1979). 2008, 51;(4):976\u201381. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.107.105767.","DOI":"10.1161\/HYPERTENSIONAHA.107.105767"},{"issue":"2","key":"953_CR9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1681\/ASN.V112319","volume":"11","author":"J Neugarten","year":"2000","unstructured":"Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11(2):319\u201329.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"953_CR10","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1097\/01.ASN.0000095249.99803.85","volume":"14","author":"MK Haroun","year":"2003","unstructured":"Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003;14(11):2934\u201341.","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"953_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/ndt\/gfg317","volume":"18","author":"TH Jafar","year":"2003","unstructured":"Jafar TH, Schmid CH, Stark PC, et al. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant. 2003;18(10):2047\u201353. https:\/\/doi.org\/10.1093\/ndt\/gfg317.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"953_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00041552-200103000-00010","volume":"10","author":"SL Seliger","year":"2001","unstructured":"Seliger SL, Davis C, Stehman-Breen C. Gender and the progression of renal disease. Curr Opin Nephrol Hypertens. 2001;10(2):219\u201325.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"953_CR13","doi-asserted-by":"publisher","unstructured":"Maric C, Sullivan S. Estrogens and the diabetic kidney. Gend Med, 2008;(5 Suppl A):S103\u201313. https:\/\/doi.org\/10.1016\/j.genm.2008.03.010.","DOI":"10.1016\/j.genm.2008.03.010"},{"issue":"4","key":"953_CR14","doi-asserted-by":"publisher","first-page":"F680","DOI":"10.1152\/ajprenal.90505.2008","volume":"296","author":"C Maric","year":"2009","unstructured":"Maric C. Sex, diabetes and the kidney. Am J Physiol Renal Physiol. 2009;296(4):F680\u20138. https:\/\/doi.org\/10.1152\/ajprenal.90505.2008.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"953_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000324562","volume":"33","author":"R Haring","year":"2011","unstructured":"\u2022 Haring R, Nauck M, V\u00f6lzke H, et al. Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy. Am J Nephrol. 2011;33(3):209\u201317. https:\/\/doi.org\/10.1159\/000324562A prospective study showing a significant relationship between low serum testosterone and mortality in men with CKD.","journal-title":"Am J Nephrol"},{"issue":"5","key":"953_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.ackd.2013.05.004","volume":"20","author":"J Neugarten","year":"2013","unstructured":"Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20(5):390\u20135. https:\/\/doi.org\/10.1053\/j.ackd.2013.05.004.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"953_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjmed.2013.10.009","volume":"127","author":"TK Roberts","year":"2014","unstructured":"Roberts TK, Kraft CS, French D, Ji W, Wu AH, Tangpricha V, et al. Interpreting laboratory results in transgender patients on hormone therapy. Am J Med. 2014;127(2):159\u201362. https:\/\/doi.org\/10.1016\/j.amjmed.2013.10.009.","journal-title":"Am J Med"},{"issue":"11","key":"953_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1373\/clinchem.2016.268839","volume":"63","author":"CT Whitley","year":"2017","unstructured":"Whitley CT, Greene DN. Transgender man being evaluated for a kidney transplant. Clin Chem. 2017;63(11):1680\u20133. https:\/\/doi.org\/10.1373\/clinchem.2016.268839.","journal-title":"Clin Chem"},{"key":"953_CR19","unstructured":"Floege J, Johnson RJ, Richard J, Feehally J. Comprehensive clinical nephrology. Saunders\/Elsevier, Amsterdam; 2010."},{"issue":"3","key":"953_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1053\/j.ajkd.2007.11.018","volume":"51","author":"LA Stevens","year":"2008","unstructured":"Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395\u2013406. https:\/\/doi.org\/10.1053\/j.ajkd.2007.11.018.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"953_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/WPS.20050","volume":"12","author":"DA Regier","year":"2013","unstructured":"Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: classification and criteria changes. World Psychiatry. 2013;12(2):92\u20138. https:\/\/doi.org\/10.1002\/WPS.20050.","journal-title":"World Psychiatry"},{"issue":"1","key":"953_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/01612840.2017.1382623","volume":"39","author":"E McCann","year":"2018","unstructured":"McCann E, Brown M. Vulnerability and psychosocial risk factors regarding people who identify as transgender. A systematic review of the research evidence. Issues Ment Health Nurs. 2018;39(1):3\u201315. https:\/\/doi.org\/10.1080\/01612840.2017.1382623.","journal-title":"Issues Ment Health Nurs"},{"issue":"3","key":"953_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jpsychores.2004.08.010","volume":"58","author":"U Hepp","year":"2005","unstructured":"Hepp U, Kraemer B, Schnyder U, et al. Psychiatric comorbidity in gender identity disorder. J Psychosom Res. 2005;58(3):259\u201361. https:\/\/doi.org\/10.1016\/j.jpsychores.2004.08.010.","journal-title":"J Psychosom Res"},{"key":"953_CR24","unstructured":"Kdigo clinical practice guideline on the evaluation and management of candidates for kidney transplantation public review draft.; 2018. https:\/\/kdigo.org\/wp-content\/uploads\/2018\/08\/KDIGO-Txp-Candidate-GL-Public-Review-Draft-Oct-22.pdf. Accessed May 6, 2019."},{"issue":"Suppl 2","key":"953_CR25","first-page":"3","volume":"1","author":"BL Kasiske","year":"2001","unstructured":"Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001;1(Suppl 2):3\u201395.","journal-title":"Am J Transplant"},{"issue":"10","key":"953_CR26","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1503\/cmaj.1041588","volume":"173","author":"G Knoll","year":"2005","unstructured":"Knoll G, Cockfield S, Blydt-Hansen T, Baran D, Kiberd B, Landsberg D, et al. Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005;173(10):S1\u201325. https:\/\/doi.org\/10.1503\/cmaj.1041588.","journal-title":"CMAJ."},{"issue":"4","key":"953_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S0033-3182(93)71865-4","volume":"34","author":"JL Levenson","year":"1993","unstructured":"Levenson JL, Olbrisch ME. Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation. Psychosomatics. 1993;34(4):314\u201323. https:\/\/doi.org\/10.1016\/S0033-3182(93)71865-4.","journal-title":"Psychosomatics."},{"issue":"5","key":"953_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/YCO.0000000000000185","volume":"28","author":"S Faeder","year":"2015","unstructured":"Faeder S, Moschenross D, Rosenberger E, Dew MA, DiMartini A. Psychiatric aspects of organ transplantation and donation. Curr Opin Psychiatry. 2015;28(5):357\u201364. https:\/\/doi.org\/10.1097\/YCO.0000000000000185.","journal-title":"Curr Opin Psychiatry"},{"issue":"2\u20133","key":"953_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10880-015-9435-6","volume":"22","author":"K Kuntz","year":"2015","unstructured":"Kuntz K, Weinland SR, Butt Z. Psychosocial challenges in solid organ transplantation. J Clin Psychol Med Settings. 2015;22(2\u20133):122\u201335. https:\/\/doi.org\/10.1007\/s10880-015-9435-6.","journal-title":"J Clin Psychol Med Settings"},{"issue":"3","key":"953_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1037\/0022-006X.70.3.771","volume":"70","author":"ME Olbrisch","year":"2002","unstructured":"Olbrisch ME, Benedict SM, Ashe K, et al. Psychological assessment and care of organ transplant patients. J Consult Clin Psychol. 2002;70(3):771\u201383.","journal-title":"J Consult Clin Psychol"},{"issue":"10","key":"953_CR31","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.2105\/AJPH.2013.301348","volume":"103","author":"NK Rotondi","year":"2013","unstructured":"Rotondi NK, Bauer GR, Scanlon K, Kaay M, Travers R, Travers A. Nonprescribed hormone use and self-performed surgeries: \u201cdo-it-yourself\u201d; transitions in transgender communities in Ontario, Canada. Am J Public Health. 2013;103(10):1830\u20136. https:\/\/doi.org\/10.2105\/AJPH.2013.301348.","journal-title":"Am J Public Health"},{"issue":"3","key":"953_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000480302","volume":"46","author":"J Yu","year":"2017","unstructured":"\u2022 Yu J, Ravel VA, You AS, et al. Association between testosterone and mortality risk among U.S. males receiving dialysis. Am J Nephrol. 2017;46(3):195\u2013203. https:\/\/doi.org\/10.1159\/000480302A retrospective study showing a significant relationship between a low testosterone and mortality in men with CKD, as well as a finding that mortality decreases with increasing serum testosterone until a value of 400ng\/dl.","journal-title":"Am J Nephrol"},{"issue":"3","key":"953_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.ajkd.2014.03.010","volume":"64","author":"KK Khurana","year":"2014","unstructured":"\u2022 Khurana KK, Navaneethan SD, Arrigain S, et al. Serum testosterone levels and mortality in men with CKD stages 3-4. Am J Kidney Dis. 2014;64(3):367\u201374. https:\/\/doi.org\/10.1053\/j.ajkd.2014.03.010A retrospective study showing a significant relationship between a specific low testosterone range and mortality in men with CKD, as well as a finding that mortality decreases with increasing serum testosterone.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"953_CR34","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/cen.12656","volume":"82","author":"M Grossmann","year":"2015","unstructured":"\u2022 Grossmann M, Hoermann R, Ng Tang Fui M, et al. Sex steroids levels in chronic kidney disease and kidney transplant recipients: associations with disease severity and prediction of mortality. Clin Endocrinol (Oxf). 2015;82(5):767\u201375. https:\/\/doi.org\/10.1111\/cen.12656A prospective study showing a significant relationship between increasing serum testosterone and decreasing mortality in men with CKD, but no such relationship in women.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"953_CR35","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1053\/j.ackd.2013.01.003","volume":"20","author":"JL Holley","year":"2013","unstructured":"Holley JL, Schmidt RJ. Changes in fertility and hormone replacement therapy in kidney disease. Adv Chronic Kidney Dis. 2013;20(3):240\u20135. https:\/\/doi.org\/10.1053\/j.ackd.2013.01.003.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"8","key":"953_CR36","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1471-0528.2000.tb10406.x","volume":"107","author":"B Szekacs","year":"2000","unstructured":"Szekacs B, Vajo Z, Varbiro S, Kakucs R, Vaslaki L, Acs N, et al. Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension. BJOG. 2000;107(8):1017\u201321.","journal-title":"BJOG."},{"issue":"16","key":"953_CR37","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/archinte.161.16.2000","volume":"161","author":"TB Monster","year":"2001","unstructured":"Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg L, Prevention of Renal and Vascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med. 2001;161(16):2000\u20135.","journal-title":"Arch Intern Med"},{"issue":"5","key":"953_CR38","doi-asserted-by":"publisher","first-page":"F1678","DOI":"10.1152\/ajprenal.00079.2007","volume":"293","author":"A Dixon","year":"2007","unstructured":"Dixon A, Maric C. 17beta-estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling. Am J Physiol Renal Physiol. 2007;293(5):F1678\u201390. https:\/\/doi.org\/10.1152\/ajprenal.00079.2007.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"953_CR39","doi-asserted-by":"publisher","first-page":"F193","DOI":"10.1152\/ajprenal.00022.2007","volume":"293","author":"M Keck","year":"2007","unstructured":"Keck M, Romero-Aleshire MJ, Cai Q, Hoyer PB, Brooks HL. Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause. Am J Physiol Renal Physiol. 2007;293(1):F193\u20139. https:\/\/doi.org\/10.1152\/ajprenal.00022.2007.","journal-title":"Am J Physiol Renal Physiol."},{"issue":"2","key":"953_CR40","doi-asserted-by":"publisher","first-page":"F399","DOI":"10.1152\/ajprenal.00195.2004","volume":"288","author":"RW Mankhey","year":"2005","unstructured":"Mankhey RW, Bhatti F, Maric C. 17beta-estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol. 2005;288(2):F399\u2013405. https:\/\/doi.org\/10.1152\/ajprenal.00195.2004.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"953_CR41","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/ki.2009.69","volume":"75","author":"P Catanuto","year":"2009","unstructured":"Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, et al. 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int. 2009;75(11):1194\u2013201. https:\/\/doi.org\/10.1038\/ki.2009.69.","journal-title":"Kidney Int"},{"issue":"6","key":"953_CR42","doi-asserted-by":"publisher","first-page":"814","DOI":"10.21037\/tau.2016.07.09","volume":"5","author":"A Majzoub","year":"2016","unstructured":"Majzoub A, Shoskes DA. A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients. Transl Androl Urol. 2016;5(6):814\u20138. https:\/\/doi.org\/10.21037\/tau.2016.07.09.","journal-title":"Transl Androl Urol"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-020-0953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-020-0953-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-020-0953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:02:27Z","timestamp":1665532947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-020-0953-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s11934-020-0953-x","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"18 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Joshua S. Jue and Mahmoud Alameddine each declare no potential conflicts of interest. Gaetano Ciancio is a section editor for <i>Current Urology Reports<\/i>.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"1"}}